Nemluvio Shows Efficacy in AD
FDA Grants Interchangeability to HADLIMA
DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
Melinda Gooderham, MSc, MD, FRCPC
Study Examines Socioeconomic Status and HS Diagnosis
DWTV Extra: Image-Guided SRT Consensus
Jacob Scott, MD
First Cell-Based Gene Therapy for RDEB
Dupixent Approved for Spontaneous Urticaria
Long-Term Bimzelx Data Presented
DWTV Extra: Culturally Conscious Dermatology
DWTV Extra: New Tapinarof Data for AD
Linda Stein Gold, MD
Emrosi Launched in the US for Rosacea
AAD Leaders Discuss New Goals and Initiatives
Nemluvio Gains Two Major Indications in Europe
Leading Dermatologists Summarize Maui Derm Presentations
Recap of Maui Derm Hawaii Meeting
Analysis Evaluates Risks of Cardiovascular Events Among Biologics for Psoriatic Diseases
Loading...
Stay current with the best on medical education
We're glad to see you're enjoying PracticalDermatology… but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.
